Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroblast Growth Factor 23”

108 trials

Showing 20 of 108 results

Not applicableUnknownNCT02331966
What this trial is testing

Molecular Pathways Involved in the Pathogenesis and Behavior of Mesenchymal Phosphaturic Tumors Causing Oncogenic Osteomalacia

Who this might be right for
Tumor Induced Oncogenic Osteomalacia
AHEPA University Hospital 10
Not applicableUnknownNCT01317173
What this trial is testing

Factors Related to the Progression of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Ankara Education and Research Hospital 90
Not applicableStudy completedNCT00477516
What this trial is testing

Association of FGF-23 and Parathyroid Hormone (PTH) in Dialysis Patients

Who this might be right for
End-Stage Renal Disease
James B. Wetmore, MD 18
Early research (Phase 1)Study completedNCT03136705
What this trial is testing

Healthy Combine Study

Who this might be right for
Healthy
Northwestern University 39
Testing effectiveness (Phase 2)Study completedNCT02163577
What this trial is testing

Study of KRN23 (Burosumab), a Recombinant Fully Human Monoclonal Antibody Against Fibroblast Growth Factor 23 (FGF23), in Pediatric Subjects With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 52
Not applicableStudy completedNCT00694824
What this trial is testing

Vascular Calcification's Risk Factors in Haemodialysis Patients

Who this might be right for
Chronic Kidney FailureInflammationVascular Calcification
IRCCS Azienda Ospedaliero-Universitaria di Bologna 253
Not applicableUnknownNCT03532568
What this trial is testing

Klotho in Chronic Kidney Disease-associated Pruritis (CKD-aP)

Who this might be right for
Chronic Kidney Disease-associated Pruritus
Cairo University 60
Testing effectiveness (Phase 2)Study completedNCT01312714
What this trial is testing

Vitamin D3 Supplementation in Dialysis Patients

Who this might be right for
End-Stage Renal Disease
Regional Hospital Holstebro 64
Early research (Phase 1)Study completedNCT02404870
What this trial is testing

Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 67
Post-approval studies (Phase 4)Study completedNCT01135615
What this trial is testing

Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)

Who this might be right for
We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.
Gulhane School of Medicine 100
Large-scale testing (Phase 3)Study completedNCT02537431
What this trial is testing

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Who this might be right for
X-linked Hypophosphatemia
Kyowa Kirin, Inc. 14
Large-scale testing (Phase 3)Study completedNCT04695860
What this trial is testing

Anti-FGF23 (Burosumab) in Adult Patients With XLH

Who this might be right for
X-linked Hypophosphatemia
Wuerzburg University Hospital 36
Not applicableStudy completedNCT01974713
What this trial is testing

Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease
Institute of Kidney Lifescience Technologies 2,530
Not applicableUnknownNCT04693962
What this trial is testing

FGF23 as a Marker of Acute Kidney Injury

Who this might be right for
Acute Kidney InjuryKidney Ischemia
University of Chile 40
Post-approval studies (Phase 4)Study completedNCT02905539
What this trial is testing

A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer

Who this might be right for
Anemia, Iron-Deficiency
Universität des Saarlandes 26
Not applicableUnknownNCT02958839
What this trial is testing

Relationship Between Fibroblast Growth Factor 23 and Recurrence of Atrial Fibrillation After Catheter Ablation

Who this might be right for
Atrial Fibrillation
Peking University Third Hospital 200
Not applicableNot Yet RecruitingNCT07453290
What this trial is testing

Dysregulation of the Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis: A Case-Control Study

Who this might be right for
Autoimmune Thyroiditis
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital 150
Not applicableStudy completedNCT00066183
What this trial is testing

Studying Phosphorus Metabolism

Who this might be right for
Phosphorus Metabolism
National Institute of Dental and Craniofacial Research (NIDCR) 100
Not applicableStudy completedNCT00843349
What this trial is testing

Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)

Who this might be right for
Kidney Disease
Myles Wolf 43
Post-approval studies (Phase 4)Study completedNCT04842032
What this trial is testing

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
Kyowa Kirin Co., Ltd. 28
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation